Feasibility of concurrent dual contrast enhancement using CEST contrast agents and superparamagnetic iron oxide particles

28Citations
Citations of this article
48Readers
Mendeley users who have this article in their library.

Abstract

A major challenge for cellular and molecular MRI is to study interactions between two different cell populations or biological processes. We studied the possibility to simultaneously image contrast agents based on two different MRI contrast mechanisms: chemical exchange saturation transfer (CEST) and enhancement of T2 relaxation. Various amounts of superparamagnetic iron oxide (SPIO) nanoparticles were mixed with a fixed concentration (250 μM) of the CEST agent poly-L-lysine. T2 maps, CEST maps, and frequency-dependent saturation spectra were then measured. Color-coded overlay maps demonstrated the feasibility of concurrent dual contrast enhancement. We found that at concentrations lower than 5 μg(Fe)/mL both contrast agents can be imaged simultaneously. At higher concentrations, the iron-based agent can be used to "shut off" the signal arising from the CEST agent. These initial findings are a first step toward using dual CEST/T2 contrast imaging for studying multiple cellular or molecular targets simultaneously in vivo. Magn Reson Med 61:970-974, 2009. © 2009 Wiley-Liss, Inc.

Cite

CITATION STYLE

APA

Gilad, A. A., Van Laarhoven, H. W. M., Mcmahon, M. T., Walczak, P., Heerschap, A., Neeman, M., … Bulte, J. W. M. (2009). Feasibility of concurrent dual contrast enhancement using CEST contrast agents and superparamagnetic iron oxide particles. Magnetic Resonance in Medicine, 61(4), 970–974. https://doi.org/10.1002/mrm.21928

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free